Literature DB >> 19959878

The suppression of hypoxia-inducible factor and vascular endothelial growth factor by siRNA does not affect the radiation sensitivity of multicellular tumor spheroids.

Yuefen Zou1, Chao Cheng, Motoko Omura-Minamisawa, Yun Kang, Takamitsu Hara, Xiaohong Guan, Tomio Inoue.   

Abstract

BACKGROUND: The hypoxic microenvironment is closely associated with the radiation resistance of tumor cells. Hypoxia induces several genes such as hypoxia-inducible factor (HIF-1) and vascular endothelial growth factor (VEGF) to promote tumor cell growth and survival. The up-regulated expression levels of HIF-1 and VEGF in tumor cells also correlate with their resistance to radiation, suggesting that these genes are potential therapeutic targets for strategies designed to enhance radiation effects. To further investigate this possibility, we investigated the effects of suppressing these genes upon the radiation sensitivity of cancer cells. We conducted these experiments using multicellular spheroids as a three-dimensional in vitro tumor model and RNA interference as the method of gene suppression.
MATERIAL AND METHODS: SQ5 human lung carcinoma cells were treated with HIF-1/VEGF siRNA and/or radiation. Reversed transfection methods were employed for the spheroids. Gene expression was analyzed using quantitative RT-PCR and western blotting. Cell toxicity was qualified by colony formation assay.
RESULTS: Compared with monolayer cells, spheroids showed up-regulated expression of HIF-1 and increased radiation resistance. Hypoxic conditions elevated the expression of HIF-1 and VEGF and enhanced the surviving fraction of spheroids after exposure to radiation. However, when the expression of HIF-1 and VEGF was down-regulated by transfection of targeting siRNA, this did not influence the cytotoxic effects of the radiation under either normoxic or hypoxic conditions.
CONCLUSIONS: We have established a method to transfect siRNA into spheroid cells. Our current data indicate that the functions of HIF-1 or VEGF are independent of radiation sensitivity in spheroids under either normoxic or hypoxic conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19959878     DOI: 10.1269/jrr.09070

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  7 in total

1.  Prognostic value of HIF-1α expression during fractionated irradiation.

Authors:  L Helbig; A Yaromina; S N Sriramareddy; S Böke; L Koi; H D Thames; M Baumann; D Zips
Journal:  Strahlenther Onkol       Date:  2012-09-29       Impact factor: 3.621

2.  ErbB3 upregulation by the HNSCC 3D microenvironment modulates cell survival and growth.

Authors:  J O Humtsoe; E Pham; R J Louie; D A Chan; R H Kramer
Journal:  Oncogene       Date:  2015-06-15       Impact factor: 9.867

3.  Conductive thermal ablation of 4T1 murine breast carcinoma reduces severe hypoxia in surviving tumour.

Authors:  Beata D Przybyla; Gal Shafirstein; Nathan A Koonce; Jessica S Webber; Robert J Griffin
Journal:  Int J Hyperthermia       Date:  2012       Impact factor: 3.914

4.  Acute toxicity of second generation HIV protease-inhibitors in combination with radiotherapy: a retrospective case series.

Authors:  Alfred P See; Jing Zeng; Phuoc T Tran; Michael Lim
Journal:  Radiat Oncol       Date:  2011-03-17       Impact factor: 3.481

5.  Hypoxia-inducible factor-1α protects cervical carcinoma cells from apoptosis induced by radiation via modulation of vascular endothelial growth factor and p53 under hypoxia.

Authors:  Zhichao Fu; Dongsheng Chen; Huihua Cheng; Fengmei Wang
Journal:  Med Sci Monit       Date:  2015-01-27

6.  Evaluation of the Combined Effect of 2ME2 and (60)Co on the Inducement of DNA Damage by IUdR in a Spheroid Model of the U87MG Glioblastoma Cancer Cell Line Using Alkaline Comet Assay.

Authors:  Samideh Khoei; Sara Delfan; Ali Neshasteh-Riz; Seyed Rabi Mahdavi
Journal:  Cell J       Date:  2011-08-24       Impact factor: 2.479

7.  Cellular Redox Status Regulates Emodin-Induced Radiosensitization of Nasopharyngeal Carcinoma Cells In Vitro and In Vivo.

Authors:  Huaxin Hou; Danrong Li; Daohai Cheng; Li Li; Ying Liu; Yi Zhou
Journal:  J Pharm (Cairo)       Date:  2013-04-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.